Adipotide (FTPP) 10mg
Adipotide, also known as FTPP, is a pioneering research chemical designed for weight management research. It functions by targeting and diminishing the blood supply to fat cells, effectively reducing their viability.
Bacteriostatic Water Offer
Receive a complimentary 30 ml bottle of Bacteriostatic Water with any purchase exceeding $500 USD. Note: This offer does not include capsule products, cosmetic peptides, promotional codes, and shipping costs.
Usage Instructions
Intended for Research Purposes Only: This product is strictly for laboratory and scientific research purposes and not for human or animal use. It must be handled by licensed professionals only. It is not suitable for use as a drug, food, or cosmetic.
Overview of Adipotide
Adipotide, also referred to as FTPP or proapoptotic peptide, uniquely targets blood vessels in fat cells, distinguishing them from other body vessels. Notably, its effectiveness was observed in research with monkeys, where it not only reduced body weight but also enhanced insulin sensitivity, demonstrating potential benefits for managing type 2 diabetes.
Molecular Composition
- Sequence: Cys-Lys-Gly-Gly-Arg-Ala-Lys-Asp-Cys—Gly-Gly--(Lys-Leu-Ala-Lys-Leu-Ala-Lys)2
- Molecular Formula: C152H252N44O42
- Molecular Weight: 2611.41 g/mol
Research Insights
- Fat Loss and Diabetes Management: Initiated in phase I clinical trials in 2011, Adipotide has shown promising results in inducing fat cell apoptosis in white adipose tissue through targeted action on blood vessels. This process not only supports rapid weight loss but also contributes to a reduced body mass index (BMI) and improved insulin resistance. Interestingly, this treatment has been linked to reduced food intake in subjects.
- Cancer Research: Adipotide's targeting mechanism may involve prohibitin, a protein potentially linked to fat cell and cancer cell blood supplies. This connection suggests possible applications in cancer therapy, focusing on non-invasive treatment options that spare healthy tissues.
- Glucose Tolerance: Adipotide has demonstrated a capacity to improve glucose tolerance independently of weight loss, suggesting a direct effect on reducing white fat. This finding is critical for developing new treatments for conditions precursory to diabetes.
Future Directions
Adipotide continues to be a focal point in research concerning fat loss and diabetes management. Its anti-angiogenic properties—targeting blood vessels—are also being explored in cancer research. Currently, Adipotide is available for sale at Peptide Gurus exclusively for educational and scientific research purposes.
Research Acknowledgment
The information and findings on Adipotide have been significantly contributed to by Dr. Logan, M.D. from Case Western Reserve University and Kirstin Barnhart, MD, Senior Pathologist at AbbVie. Their work underscores the potential of Adipotide in scientific and medical research. Neither endorses nor recommends the use of Adipotide outside of a research setting.
